Mutual Funds that own Medios AG
Baring German Growth Trust
215,000
1.57%
0
0.56%
10/31/2017
Arnica European Opportunity Fund
206,995
1.52%
162,995
6.85%
12/31/2017
109,063
0.8%
0
3.47%
07/31/2018
PWM Vermoegensfondsmandat - DWS - High Conviction Equity (EUR)
80,769
0.59%
0
1.72%
07/31/2018
80,487
0.59%
-24,513
1.04%
07/31/2018
DJE - Absolut
71,000
0.52%
0
0.69%
06/29/2018
Nordea European Smaller Companies Fund
64,600
0.47%
64,600
1.69%
05/31/2018
DekaLux - Mid Cap TF
57,946
0.42%
-557
0.8%
03/29/2018
DWS German Equities Typ O
48,462
0.36%
0
0.23%
07/31/2018
47,500
0.35%
2,500
0.56%
05/31/2018
| Address |
Friedrichstrasse 113a
Berlin Berlin 10117
Germany
|
|
Employees
|
- |
| Website |
http://www.medios.ag |
| Updated |
07/08/2019 |
| Medios AG engages in providing specialty pharmaceutical drugs. These are medicines for patients with rare or chronic diseases such as cancer, HIV and hepatitis, whose personalized therapy is often tedious and cost-intensive due to their individual requirements. It operates through the following segments: Specialty Pharma Trade, Personalized Preparations, and Shared Services. |
